Medical Developments International

An advanced range of Space Chamber, for hospital and home use, that universally fit most asthma and chronic obstructive pulmonary disease (COPD) pressurised metered dose inhalers.

The company offers registration to access resources related to acute pain.

MDI designs, develops, and distributes medical devices to enhance patient care globally.

Home > At a Glance > Corporate Governance

Medical Developments International Pty Ltd, founded by Dr David Komesaroff

Advancing research and development, quality assurance and supply chain solutions.

Manufacturer and supplier of analgesia delivery for acute trauma and procedural pain. Check for local registration.

Medical Developments International (ASX:MVP) reports that its Penthrox product line is driving growth, aiding the company’s business recovery efforts. Penthrox, a medical gas used primarily in pain management and sedation, contributes to revenue stabilization. The company highlights the product’s expanding adoption as a key factor in its operational rebound.

Sep 2026KalkineNews article

Medical Developments International Limited (ASX:MVP) is an Australian medical technology company awaiting a potential catalyst that could re-rate its stock. The company operates in the healthcare sector, focusing on medical devices and clinical solutions. Investors speculate whether upcoming clinical trials or commercial milestones could drive significant revaluation.

Sep 2026KalkineNews article

Medical Developments International reports a **9% increase in FY26 revenue to $42.6 million**, driven by stronger demand for its **Penthrox** product. The company’s pediatric approval in the **UK and Europe** expands its market reach, supporting improved cash flow and operational momentum.

Aug 2026Small CapsNews article

Medical Developments International reports higher sales for fiscal year 2026, driven by earnings call updates. The company highlights growth in its medical technology segment, though its stock price declines following the announcement. Analysts note continued demand for its diagnostic and surgical tools among healthcare providers.

Aug 2026Investing.comNews article